Do prenatal antibiotics weaken breast milk immunity? A new study aims to find out

Could antibiotics taken during pregnancy weaken the protective power of breast milk? A new study will explore whether prenatal antibiotic exposure reduces key immune factors in breast milk, potentially altering a newborn’s gut microbiome and immune resilience. Study Protocol: Effect of prenatal antibiotics on breast milk and neonatal IgA and microbiome: a case-control translational study … Read more

Alcohol Cancer Warning Labels Should Be Mandatory

Prominent, mandatory health warning labels on alcohol products should be implemented across Europe to raise awareness on the link between drinking and cancer, a new report by the World Health Organization (WHO) has said.  The report, published on Friday, revealed that alcohol consumption in the European Union (EU) per capita in 2019 was twice the … Read more

New atlas reveals aging’s impact on breast tissue and cancer risk

Aging is a privilege, but it also brings risks-including an increased likelihood of developing age-related diseases including cancer. Researchers at The Jackson Laboratory (JAX) have created a landmark atlas of how healthy breast tissue ages, revealing key cellular, molecular, and genetic changes that may tip the balance toward breast cancer development. Their findings, published recently … Read more

Ritlecitinib Shows Long-Term Benefits for Alopecia Areata

Archyde > Long-Term Efficacy and Safety of Ritlecitinib in Alopecia Areata Table of Contents 1. Long-Term Efficacy and Safety of Ritlecitinib in Alopecia Areata 2. Promising Results: Hair Regrowth Sustains Over Time 3. Safety Profile: Favorable Despite Side Effects 4. What Are the Key Differences Between the ALLEGRO-LT Study and Previous Ritlecitinib Trials for AA? … Read more

Ritlecitinib Shows Long-Term Benefits in Alopecia Areata

TOPLINE: Ritlecitinib demonstrates long-term improvements in regrowth of scalp hair, eyebrows, and eyelashes at 24 months in adults and adolescents with alopecia areata (AA) and ≥ 25% scalp hair loss. METHODOLOGY: Researchers evaluated outcomes in 449 de novo adult and adolescent patients (mean age, 32.9 years) with AA and ≥ 25% scalp hair loss, enrolled … Read more

Less Invasive Surgery Appears Safe in Node+ Breast Cancer

TOPLINE: Patients with clinically node-negative breast cancer after neoadjuvant chemotherapy demonstrated low axillary and locoregional recurrence rates after sentinel lymph node biopsy (SLNB) or targeted axillary dissection. METHODOLOGY: More conservative treatment options for women with node-positive breast cancer include SLNB and targeted axillary dissection. However, data comparing patient outcomes after targeted axillary dissection and SLNB … Read more

Breast Cancer Screening at 40 Seems Cost-Effective in Canada

Earlier initiation of digital screening mammography at age 40 years leads to substantial healthcare savings by reducing the cost of breast cancer treatment, according to a new cost-effectiveness study. Based on data in Canada for a population-based breast screening program, biennial screening for ages 40-74 years results in fewer deaths, more years of life for … Read more

Millions of American Women Missing Crucial Breast Cancer Screenings

Millions of American Women Skipping Crucial Breast Cancer Screenings Table of Contents Millions of American Women Skipping Crucial Breast Cancer Screenings study Reveals Alarming Gap in Mammogram Rates, Highlighting Disparities Disparities in Screening Rates Raise Concerns Access to Care: A Key Factor in Missed Screenings Bridging the Gap: A Call for Action Real Women, Real … Read more